arrow
D

Dashan Ai

Ant Group
H指数:13
被引数:747

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Postoperative chemoradiotherapy for esophageal squamous cell Carcinoma: Results from ESO-Shanghai 17 and joint analyses for phase II clinical trials

食管鳞状细胞癌的术后化放疗:来自ESO-Shanghai 17和联合分析的II期临床试验结果

2025-11-210
OAAI
ESO-Shanghai 20: phase III clinical trial of anti-PD-1 therapy with local intervention for oligometastatic ESCC

ESO-上海20:局部干预联合抗PD-1疗法治疗寡转移性ESCC的III期临床试验

2025-07-300
OA
Dose escalation based on 18F-FDG PET/CT response in definitive chemoradiotherapy of locally advanced esophageal squamous cell carcinoma: a phase III, open-label, randomized, controlled trial (ESO-Shanghai 12)
2022-07-297
OAAI
Comparative genomic analysis of esophageal squamous cell carcinoma between Asian and Caucasian patient populations
2017-11-1693
OAAI